Livestock Dewormers Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

Livestock dewormers, also known as anthelmintics or antiparasitics, are veterinary pharmaceutical products used to treat and prevent internal parasite infections such as roundworms, tapeworms, flukes, and lungworms in farm animals. The global market sits in the range of roughly $7.25 to $8.4 billion depending on the source and year of valuation, with 2025 estimates clustered around $8.1 to $8.4 billion. As a subsegment of the broader animal parasiticides category, valued at roughly $11.2 billion in 2024, livestock dewormers represent the dominant portion of that broader market.

• •Market sits within the broader veterinary parasiticides sector, valued at roughly $13.6 billion globally in 2025
• •Livestock dewormers account for approximately 58% of the overall animal dewormer market by revenue
• •No single official statistical agency globally tracks this market; sizing is compiled by private research firms

The primary engine of market growth is rising global demand for meat, dairy, and eggs, which is expanding livestock herd sizes, particularly in emerging economies. Parasites impose significant economic losses through reduced weight gain, lower milk yields, fertility issues, and mortality, giving producers a clear financial incentive to maintain deworming programs. Growing concern over anthelmintic resistance, where parasites become less responsive to existing drugs, is also pushing demand for newer formulations and rotating treatment protocols.

• •FAO livestock headcount data shows expanding herd populations globally, directly expanding the addressable market
• •Anthelmintic resistance in parasites is driving demand for novel drug classes and combination products
• •Stringent meat quality and food safety regulations are reinforcing the use of certified antiparasitic treatments

The market is segmented by product type, including benzimidazoles, macrocyclic lactones, imidazothiazoles, and tetrahydropyrimidines, and by animal species, with cattle typically representing the largest segment due to their high economic value and parasite burden. Regionally, North America and Europe have historically held the largest market share, supported by intensive livestock farming systems and strong veterinary infrastructure. The Asia-Pacific region is expected to see the fastest growth, driven by rising meat consumption, expanding commercial livestock operations, and increasing veterinary penetration in countries such as China, India, and Brazil.

• •Cattle segment typically leads the species-based breakdown, followed by sheep and goats, then swine and poultry
• •North America and Europe account for the largest combined regional share, with mature but steady demand
• •Asia-Pacific and Latin America are the fastest-growing regions due to intensifying livestock production

What are the recent trends and outlook?

The market is expected to continue growing through 2030 and beyond at a rate of roughly 4.5% to 5% per year, with several structural trends shaping its evolution. Strategic consolidation among animal health companies, driven by mergers and acquisitions, is expected to continue as firms seek to expand their antiparasitic product lines and geographic reach. The growing problem of dewormer resistance is likely to spur increased investment in research for new active ingredients, as well as greater emphasis on precision livestock management and parasite monitoring tools.

• •Combination products addressing multiple parasite types are gaining market share over single-ingredient treatments
• •Rising generic competition will put price pressure on older products as patents expire over the forecast period
• •Integrated parasite management strategies, combining dewormers with pasture rotation and diagnostics, are reshaping how producers approach treatment